Biogen plans to advance an experimental drug for Alzheimer's disease to late-stage testing despite disappointing mid-stage trial data, the company said Thursday. Biogen plans to move the drug into ...

Analysts' ratings for Biogen (NASDAQ:BIIB) over the last quarter vary from bullish to bearish, as provided by 17 analysts. The following table summarizes their recent ratings, shedding light on the ...

Bone grafts treat traumatic injuries and help rejuvenate aging joints. Autografts use tissue from a person’s own body, while allografts use tissue from another person’s body. The different types of ...

When tissue is transplanted from one person to another, it is called an allograft transplant. The type of tissue that can be used in allograft transplants ranges from bones and skin to heart valves ...

Biogen to pay $18.9 million to settle investors' claims over Alzheimer's drug Biogen has agreed to pay $18.9 million to resolve a lawsuit alleging that it misled investors about the commercial ...